These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8340137

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biology of proinflammatory cytokines and their antagonists.
    Moldawer LL.
    Crit Care Med; 1994 Jul; 22(7):S3-7. PubMed ID: 8026189
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of endogenous TNF formation by pentoxifylline.
    Zabel P, Schade FU, Schlaak M.
    Immunobiology; 1993 Apr; 187(3-5):447-63. PubMed ID: 8330908
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of TNF-alpha, IL-1beta and IL-6 in the local tissue damage induced by Bothrops asper snake venom: an experimental assessment in mice.
    Chaves F, Teixeira CF, Gutiérrez JM.
    Toxicon; 2005 Feb; 45(2):171-8. PubMed ID: 15626366
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production.
    Greeneltch KM, Haudenschild CC, Keegan AD, Shi Y.
    Brain Behav Immun; 2004 Sep; 18(5):476-84. PubMed ID: 15265541
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC.
    Nature; 1990 Dec 06; 348(6301):550-2. PubMed ID: 2147233
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
    Libert C, Vink A, Coulie P, Brouckaert P, Everaerdt B, Van Snick J, Fiers W.
    Eur J Immunol; 1992 Oct 06; 22(10):2625-30. PubMed ID: 1327800
    [Abstract] [Full Text] [Related]

  • 14. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock.
    Beutler B.
    New Horiz; 1993 Feb 06; 1(1):3-12. PubMed ID: 7922391
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.
    Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG.
    J Immunol; 1992 May 01; 148(9):2724-30. PubMed ID: 1315357
    [Abstract] [Full Text] [Related]

  • 17. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
    Gelin J, Moldawer LL, Lönnroth C, Sherry B, Chizzonite R, Lundholm K.
    Cancer Res; 1991 Jan 01; 51(1):415-21. PubMed ID: 1703040
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.